Back to SPARK articles

Case Study

Multi-site non-interventional study incorporating patient-reported outcomes (PROs)

A global biopharmaceutical company required UK delivery of a multi-country, cross-sectional non-interventional study investigating the burden of three dermatological conditions. The challenge was obtaining regulatory approvals, activating NHS sites and recruiting three patient cohorts simultaneously while accommodating multiple clinical and patient-reported outcome assessments.

SPARK managed end-to-end UK study delivery, including IRAS/HRA/REC submissions, protocol amendments, feasibility assessments, site selection, contracting and initiation. Working closely with the sponsor’s medical science liaisons, we implemented recruitment tracking, streamlined study materials and PRO completion processes, and activated two additional sites to maintain recruitment momentum.

Successfully recruited all 250 patients across 10 NHS sites, achieving 100% of recruitment targets for all three cohorts. Regulatory amendments were approved without disrupting recruitment, while two additional sites contributed 38 patients. The study demonstrated SPARK’s ability to deliver complex, multi-site NHS non-interventional research efficiently and at scale.

Delivering 100% of patient recruitment targets across three disease cohorts and 10 NHS sites through integrated regulatory, operational and recruitment management.